Inventor · disambiguated record
Anna Ericsson
Also filed as: ERICSSON ANNA · ERICSSON ANNA M
58 granted patents·30 pending applications·865 citations·filing 1998–2024
99Inventor score
Top patents by PatentIndex Score
88 records- 0198US10550098B2Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitorsFORMA THERAPEUTICS INC·Filed 2019·Granted Feb 4, 2020·17 cites·25 claims
- 0298US10414752B2Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Sep 17, 2019·19 cites·20 claims
- 0398US9834539B2Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitorsFORMA THERAPEUTICS INC·Filed 2015·Granted Dec 5, 2017·28 cites·108 claims
- 0498US9624175B2Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitorsFORMA THERAPEUTICS INC·Filed 2015·Granted Apr 18, 2017·25 cites·39 claims
- 0598US9624216B2Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitorsFORMA THERAPEUTICS INC·Filed 2015·Granted Apr 18, 2017·26 cites·74 claims
- 0698US7297709B2Indazole, benzisoxazole, and benzisothiazole kinase inhibitorsABBOTT LAB·Filed 2004·Granted Nov 20, 2007·92 cites·37 claims
- 0797US11980611B2Treating sickle cell disease with a pyruvate kinase R activating compoundNOVO NORDISK HEALTHCARE AG·Filed 2022·Granted May 14, 2024·3 cites·4 claims
- 0897US11844787B2Activating pyruvate kinase RNOVO NORDISK HEALTHCARE AG·Filed 2021·Granted Dec 19, 2023·5 cites·4 claims
- 0997US11649242B2Pyrrolopyrrole compositions as pyruvate kinase (PKR) activatorsFORMA THERAPEUTICS INC·Filed 2021·Granted May 16, 2023·5 cites·4 claims
- 1097US11498913B2Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitorsFORMA THERAPEUTICS INC·Filed 2020·Granted Nov 15, 2022·4 cites·18 claims
- 1197US11071725B2Activating pyruvate kinase RFORMA THERAPEUTICS INC·Filed 2020·Granted Jul 27, 2021·8 cites·21 claims
- 1297US10675274B2Activating pyruvate kinase RFORMA THERAPEUTICS INC·Filed 2019·Granted Jun 9, 2020·12 cites·13 claims
- 1397US9771349B2Pyridinyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitorsFORMA THERAPEUTICS INC·Filed 2015·Granted Sep 26, 2017·27 cites·68 claims
- 1497US9365579B2Tricyclic compoundsABBVIE INC·Filed 2015·Granted Jun 14, 2016·50 cites·15 claims
- 1596US11014927B2Pyrrolopyrrole compositions as pyruvate kinase (PKR) activatorsFORMA THERAPEUTICS INC·Filed 2018·Granted May 25, 2021·6 cites·3 claims
- 1696US10005734B2Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitorsFORMA THERAPEUTICS INC·Filed 2015·Granted Jun 26, 2018·25 cites·75 claims
- 1796US9902728B2Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2015·Granted Feb 27, 2018·24 cites·40 claims
- 1896US9815817B2Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitorsFORMA THERAPEUTICS INC·Filed 2015·Granted Nov 14, 2017·24 cites·48 claims
- 1996US8962629B2Tricyclic compoundsWISHART NEIL·Filed 2009·Granted Feb 24, 2015·56 cites·53 claims
- 2095US10934299B2Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitorsVALO EARLY DISCOVERY INC·Filed 2019·Granted Mar 2, 2021·7 cites·20 claims
- 2195US10889567B2Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitorsFORMA THERAPEUTICS INC·Filed 2019·Granted Jan 12, 2021·5 cites·21 claims
- 2295US10377760B2Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Aug 13, 2019·17 cites·20 claims
- 2395US10280150B2Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitorsFORMA TM2 INC·Filed 2017·Granted May 7, 2019·19 cites·2 claims
- 2495US10266495B2Phenyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitorsFORMA TM2 INC·Filed 2018·Granted Apr 23, 2019·19 cites·9 claims
- 2595US10253015B2Pyridinyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitorsFORMA TM2 INC·Filed 2018·Granted Apr 9, 2019·20 cites·12 claims
- 2695US8785639B2Substituted dihydropyrazolo[3,4-D]pyrrolo[2,3-B]pyridines and methods of use thereofWISHART NEIL·Filed 2010·Granted Jul 22, 2014·57 cites·9 claims
- 2795US8008481B2Indazole compoundsERICSSON ANNA M·Filed 2007·Granted Aug 30, 2011·112 cites·8 claims
- 2894US10870648B2Inhibiting CREB binding protein (CBP)FORMA THERAPEUTICS INC·Filed 2019·Granted Dec 22, 2020·8 cites·24 claims
- 2994US10294206B2Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitorsFORMA TM2 INC·Filed 2015·Granted May 21, 2019·7 cites·16 claims
- 3093US8063091B2Indazole, benzisoxazole, and benzisothiazole kinase inhibitorsDAI YUJIA·Filed 2009·Granted Nov 22, 2011·13 cites·21 claims
- 3192US10577329B2Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitorsFORMA THERAPEUTICS INC·Filed 2019·Granted Mar 3, 2020·4 cites·20 claims
- 3291US11254674B2Inhibiting CREB binding protein (CBP)FORMA THERAPEUTICS INC·Filed 2020·Granted Feb 22, 2022·2 cites·21 claims
- 3391US11001588B2Activating pyruvate kinase R and mutants thereofFORMA THERAPEUTICS INC·Filed 2019·Granted May 11, 2021·3 cites·15 claims
- 3491US10407419B2Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitorsFORMA THERAPEUTICS INC·Filed 2015·Granted Sep 10, 2019·5 cites·5 claims
- 3590US2024391922A1Pyrrolopyrrole compositions as pyruvate kinase (pkr) activatorsNovo Nordisk Heathcare AG·Filed 2024·Application pending·0 cites
- 3689US7598283B2Indazole, benzisoxazole, and benzisothiazole kinase inhibitorsABBOTT LAB·Filed 2007·Granted Oct 6, 2009·5 cites·12 claims
- 3788US12071440B2Pyrrolopyrrole compositions as pyruvate kinase (PKR) activatorsNOVO NORDISK HEALTHCARE AG·Filed 2023·Granted Aug 27, 2024·0 cites·4 claims
- 3888US10550099B2Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitorsFORMA THERAPEUTICS INC·Filed 2019·Granted Feb 4, 2020·4 cites·15 claims
- 3987US12275715B2Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitorsFORMA THERAPEUTICS INC·Filed 2023·Granted Apr 15, 2025·0 cites·23 claims
- 4087US10807976B2Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitorsFORMA THERAPEUTICS INC·Filed 2019·Granted Oct 20, 2020·2 cites·18 claims
- 4185US7091227B2Benzothiazole derivativesABBOTT GMBH & CO KG·Filed 2001·Granted Aug 15, 2006·29 cites·40 claims
- 4285US6462036B1Tricyclic pyrazole derivativesBASF AG·Filed 2000·Granted Oct 8, 2002·38 cites·55 claims
- 4384US12128035B2Activating pyruvate kinase RNOVO NORDISK HEALTHCARE AG·Filed 2022·Granted Oct 29, 2024·1 cites·21 claims
- 4483US2023125739A1Pyridin-2(1h)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitorsFORMA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4582US7939544B2Octahydropentalene compounds as chemokine receptor antagonistsABBOTT LAB·Filed 2008·Granted May 10, 2011·5 cites·18 claims
- 4681US11801243B2Bromodomain inhibitors for androgen receptor-driven cancersFORMA THERAPEUTICS INC·Filed 2021·Granted Oct 31, 2023·1 cites·23 claims
- 4780US8598199B2Octahydropentalene compounds as chemokine receptor antagonistsGEORGE DAWN M·Filed 2011·Granted Dec 3, 2013·5 cites·20 claims
- 4879US2024150349A1Tetrahydro-imidazo quinoline compositions as cbp/p300 inhibitorsFORMA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4978US11292791B2Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Apr 5, 2022·1 cites·20 claims
- 5077US7468371B2Tricyclic pyrazole kinase inhibitorsABBOTT LAB·Filed 2005·Granted Dec 23, 2008·4 cites·20 claims
Showing the top 50 of 88 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →